250 related articles for article (PubMed ID: 31111610)
1. Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
Ortiz V; Estevez-Ordonez D; Montalvan-Sanchez E; Urrutia-Argueta S; Israel D; Krishna US; Romero-Gallo J; Wilson KT; Peek RM; Dominguez R; Morgan DR
Helicobacter; 2019 Aug; 24(4):e12595. PubMed ID: 31111610
[TBL] [Abstract][Full Text] [Related]
2. The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer.
Wang D; Guo Q; Yuan Y; Gong Y
BMC Microbiol; 2019 Jul; 19(1):152. PubMed ID: 31272365
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for
Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y
Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
Dekhnich N; Ivanchik N; Kozlov R; Alimov A; Steshits A; Kirsov P; Pandav K
Helicobacter; 2018 Dec; 23(6):e12545. PubMed ID: 30324756
[TBL] [Abstract][Full Text] [Related]
5. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
Pandya HB; Agravat HH; Patel JS; Sodagar NR
Indian J Med Microbiol; 2014; 32(4):408-13. PubMed ID: 25297026
[TBL] [Abstract][Full Text] [Related]
6. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
[TBL] [Abstract][Full Text] [Related]
8. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
[TBL] [Abstract][Full Text] [Related]
9. Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.
Lee JY; Kim N; Nam RH; In Choi S; Lee JW; Lee DH
Helicobacter; 2019 Dec; 24(6):e12660. PubMed ID: 31507036
[TBL] [Abstract][Full Text] [Related]
10. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
11. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland.
Karczewska E; Wojtas-Bonior I; Sito E; Zwolińska-Wcisło M; Budak A
Pharmacol Rep; 2011; 63(3):799-807. PubMed ID: 21857091
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Helicobacter pylori resistance to certain antibiotics at An-Najah University Hospital: a cross-sectional study.
Abdoh Q; Alnees M; Kharraz L; Ayoub K; Darwish A; Awwad M; Najajra D; Khraim J; Awad W; Sbaih A; Turman S; Abu Hamdeh N
Sci Rep; 2024 Jun; 14(1):14542. PubMed ID: 38914675
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia.
Arévalo A; Otero WA; Trespalacios AA
Biomedica; 2019 May; 39(s1):125-134. PubMed ID: 31529855
[TBL] [Abstract][Full Text] [Related]
15. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option.
Eisig JN; Silva FM; Barbuti RC; Navarro-Rodriguez T; Moraes-Filho JP; Pedrazzoli J
Arq Gastroenterol; 2011; 48(4):261-4. PubMed ID: 22147131
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori pathogenicity and primary antimicrobial resistance in Northern Spain.
Fernández-Reyes M; Tamayo E; Rojas-Rengifo D; Fischer W; Carrasco-García E; Alonso M; Lizasoain J; Bujanda L; Cosme Á; Montes M
Eur J Clin Invest; 2019 Aug; 49(8):e13150. PubMed ID: 31192451
[TBL] [Abstract][Full Text] [Related]
18. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
19. Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV-positive than HIV-negative individuals: A descriptive observational study.
Nkuize M; Vanderpas J; Buset M; Gomez-Galdon M; Delforge M; Miendje-Deyi VY; Muls V; De Wit S
Microbiologyopen; 2021 Jun; 10(3):e1184. PubMed ID: 34180600
[TBL] [Abstract][Full Text] [Related]
20. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
Lu HH; Lai FP; Lo HY; Sheu BS; Yang YJ
Helicobacter; 2019 Oct; 24(5):e12633. PubMed ID: 31295754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
